Skip to main content
CA

Candesant Biomedical

San Francisco, United States
Last funding
$35.0M
Series BJun 2023

Candesant Biomedical develops treatment for excessive sweating and hyperhidrosis.

Backed byPolaris PartnersCorrelation VenturesAstiaKCK Medtech

About Candesant Biomedical

How much funding has Candesant Biomedical raised?

Candesant Biomedical has raised $35.0M in total funding. The most recent round was Series B. The last funding was announced in June 2023.

Who are Candesant Biomedical's investors?

Candesant Biomedical's investors include Polaris Partners, Correlation Ventures, Astia, KCK Medtech.

Where is Candesant Biomedical headquartered?

Candesant Biomedical is headquartered in San Francisco, United States.

What does Candesant Biomedical do?

Candesant Biomedical develops treatment for excessive sweating and hyperhidrosis.

What stage is Candesant Biomedical at?

Candesant Biomedical is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Candesant Biomedical — Funding & Investors." VCBacked, June 6, 2023, https://www.vcbacked.co/company/candesant-biomedical. Accessed November 19, 2026.
APA
VCBacked. (2023). Candesant Biomedical — Funding & Investors. Retrieved November 19, 2026, from https://www.vcbacked.co/company/candesant-biomedical
Wikipedia (cite web)
{{cite web |title=Candesant Biomedical — Funding & Investors |url=https://www.vcbacked.co/company/candesant-biomedical |website=VCBacked |access-date=November 19, 2026}}

Profile data sourced and verified per the VCbacked methodology · Last funding round dated

Work at Candesant Biomedical? Request a listing update

Founder contacts
m***@candesant.com
linkedin.com/in/●●●●●●
Emails, phones & LinkedIn · 41,000+ verified contacts
Get instant access →